This document provides an overview of DNA structure and the different forms it can take. It discusses the primary structures of DNA including nucleotides, nucleosides, and bases. It then describes the canonical B-DNA double helical structure proposed by Watson and Crick, including base pairing, base stacking, and the forces that stabilize the structure. Finally, it briefly discusses alternative A-form and Z-form double helical structures and their biological relevance.
EMMA International Consulting Group CEO, Dr. Carmine Jabri, will be cohosting a webinar with Jan Flegeau, Director of Regulatory Affairs, to give an overview of what’s to come from the EU MDR.
The document discusses generics and biosimilars. It provides background on the Hatch-Waxman Act which established the abbreviated new drug application process for generic small molecule drugs. It also discusses the Biologics Price Competition and Innovation Act which created an abbreviated licensure pathway for biosimilar biologics. The manufacturing of biologics is more complex than small molecules due to production in living cells, and biosimilars are highly similar but not identical copies. Clinical trials are required to demonstrate biosimilarity in terms of safety and efficacy.
The document provides an overview of the marketing authorisation procedures for medicines in the European Union, with a focus on the centralised procedure. It discusses the historical development of regulation, the roles of the European Medicines Agency and other EU institutions. The centralised procedure is mandatory for certain drug classes and allows for a single marketing authorisation valid across all EU member states. The process involves evaluation of documentation like the common technical document by committees like CHMP and ultimately decisions made by the European Commission.
The document provides information on variations and renewals of marketing authorizations in the European Union. It discusses the different types of variations (Type IA, IB, II and extensions), including examples. It describes the classification guidelines and regulations governing variations in the EU. It also outlines the documentation requirements, timelines and procedures for notification and approval of variations. Finally, it discusses marketing authorization renewals in the EU, noting they must be applied for at least 9 months before expiration for the authorization to remain valid indefinitely.
The document provides information on the structure of DNA and RNA. It discusses how DNA was discovered to have a double helix structure by Watson and Crick in 1953 based on prior work by scientists like Franklin, Wilkins, Chargaff and Pauling. It describes the key components of DNA including the sugar-phosphate backbone, nitrogenous bases, and how the bases pair up in the double helix structure. It also discusses different DNA structures like A, B and Z-DNA and how DNA packages into nucleosomes and chromosomes. For RNA, it notes that it is similar to DNA but contains the sugar ribose and base uracil instead of thymine.
The discovery of the DNA double helix structure in 1953 by James Watson and Francis Crick was one of the greatest scientific achievements of the 20th century. They were able to determine that DNA consists of two strands coiled around each other to form a double helix. Each strand is made up of a backbone of alternating sugar and phosphate groups with nitrogenous bases protruding from the sugars. The bases on one strand form hydrogen bonds with complementary bases on the other strand. Watson and Crick's double helix model explained how DNA could replicate itself and be stable within organisms. Their discovery fundamentally changed our understanding of genetics and laid the foundation for modern molecular biology and genetic engineering.
1. DNA is made up of deoxyribose, phosphate groups, and four nitrogenous bases (adenine, guanine, cytosine, thymine).
2. The bases pair up through hydrogen bonding between complementary base pairs (adenine with thymine, cytosine with guanine).
3. The paired bases and sugar-phosphate backbone form the structure of the DNA double helix, with the bases in the middle and the backbones on the outside.
EMMA International Consulting Group CEO, Dr. Carmine Jabri, will be cohosting a webinar with Jan Flegeau, Director of Regulatory Affairs, to give an overview of what’s to come from the EU MDR.
The document discusses generics and biosimilars. It provides background on the Hatch-Waxman Act which established the abbreviated new drug application process for generic small molecule drugs. It also discusses the Biologics Price Competition and Innovation Act which created an abbreviated licensure pathway for biosimilar biologics. The manufacturing of biologics is more complex than small molecules due to production in living cells, and biosimilars are highly similar but not identical copies. Clinical trials are required to demonstrate biosimilarity in terms of safety and efficacy.
The document provides an overview of the marketing authorisation procedures for medicines in the European Union, with a focus on the centralised procedure. It discusses the historical development of regulation, the roles of the European Medicines Agency and other EU institutions. The centralised procedure is mandatory for certain drug classes and allows for a single marketing authorisation valid across all EU member states. The process involves evaluation of documentation like the common technical document by committees like CHMP and ultimately decisions made by the European Commission.
The document provides information on variations and renewals of marketing authorizations in the European Union. It discusses the different types of variations (Type IA, IB, II and extensions), including examples. It describes the classification guidelines and regulations governing variations in the EU. It also outlines the documentation requirements, timelines and procedures for notification and approval of variations. Finally, it discusses marketing authorization renewals in the EU, noting they must be applied for at least 9 months before expiration for the authorization to remain valid indefinitely.
The document provides information on the structure of DNA and RNA. It discusses how DNA was discovered to have a double helix structure by Watson and Crick in 1953 based on prior work by scientists like Franklin, Wilkins, Chargaff and Pauling. It describes the key components of DNA including the sugar-phosphate backbone, nitrogenous bases, and how the bases pair up in the double helix structure. It also discusses different DNA structures like A, B and Z-DNA and how DNA packages into nucleosomes and chromosomes. For RNA, it notes that it is similar to DNA but contains the sugar ribose and base uracil instead of thymine.
The discovery of the DNA double helix structure in 1953 by James Watson and Francis Crick was one of the greatest scientific achievements of the 20th century. They were able to determine that DNA consists of two strands coiled around each other to form a double helix. Each strand is made up of a backbone of alternating sugar and phosphate groups with nitrogenous bases protruding from the sugars. The bases on one strand form hydrogen bonds with complementary bases on the other strand. Watson and Crick's double helix model explained how DNA could replicate itself and be stable within organisms. Their discovery fundamentally changed our understanding of genetics and laid the foundation for modern molecular biology and genetic engineering.
1. DNA is made up of deoxyribose, phosphate groups, and four nitrogenous bases (adenine, guanine, cytosine, thymine).
2. The bases pair up through hydrogen bonding between complementary base pairs (adenine with thymine, cytosine with guanine).
3. The paired bases and sugar-phosphate backbone form the structure of the DNA double helix, with the bases in the middle and the backbones on the outside.
The document describes improvements made to the process for manufacturing the potential therapeutic compound ELN 296571. It summarizes the original multi-step synthesis route and key intermediate compound ELN 361973. The route was optimized to require fewer steps and produce ELN 361973 in higher yields and purity. Later, production of the important intermediate ELN 361973 was outsourced to improve the overall process.
This document discusses purine and pyrimidine metabolism. It covers the biosynthesis of purines through 11 steps, degradation of purines to uric acid, medical conditions related to purine metabolism like Lesch-Nyhan and ADA deficiency, the causes and treatment of gout, and drugs used to treat gout like colchicine, probenecid, and allopurinol.
Esta ha sido una de las conferencias que mas me ha gustado darla por lo moderno en el tratamiento de la DBM tipo 2 ,con el uso de la Linagliptina completamos el cuadro
The Mitsunobu reaction allows the conversion of alcohols to various functional groups using trialkyl/triaryl phosphine and dialkyl azodicarboxylate reagents. It proceeds via an oxidation-reduction mechanism. Common applications include esterification, etherification, and N-alkylation reactions. Recent advances have focused on replacing conventional reagents to improve selectivity and yields. The Mitsunobu reaction has been widely used in the synthesis of natural products and pharmaceuticals.
The document discusses factors that determine the biological activity of phosphodiesterase inhibitors. It finds that inhibitory activity mainly depends on bond stretch energy, geometric section, number of types of molecular associates, molecule surface area, sum of atomic volumes, and sum of free carbon atomic volumes and surfaces. Inhibitory activity is influenced by the molecule's geometry and ability to complementarily fit and strongly interact with the binding site. Virtual receptor modeling shows the most active structure occupying the receptor space most completely.
This document summarizes the optimization of an organocatalytic domino Michael-Aldol reaction to synthesize bispirooxindoles. Various cinchona alkaloid derivatives were evaluated as catalysts, with a trifunctional S-binaphthyl diamine catalyst (VIII) giving excellent diastereoselectivity and enantioselectivity. Reaction conditions such as temperature, solvent, and substrate scope were varied, demonstrating good yields and selectivity for a range of substrates. A different protecting group was also investigated, and bispirooxindoles were successfully deprotected to give the corresponding amines in high yields and selectivity.
The document lists 12 chemical reactions and asks the reader to identify missing dipoles, dipolarophiles, and cycloducts in each case. The reactions involve azide substitutions, halogenations, nitrene additions, and 1,3-dipolar cycloadditions to form five-membered heterocycles. Key intermediates and products include azides, nitriles, oxazoles, isoxazoles, and triazoles.
The big topic of the last few years, the use of small organic molecules to catalyse enantioselective transformations. This lecture will start with proline before moving on to some of MacMillan's contributions to this field and, finally, finish with hydrogen bond catalysts and Brønsted acids.
This chapter outline discusses DNA and RNA structure and function, including:
- The discovery that DNA is the genetic material through experiments with viruses.
- The double helix structure of DNA determined by Watson and Crick based on data from Franklin and others.
- DNA replication through semiconservative replication to produce identical copies.
- Transcription of DNA to mRNA and the three types of RNA (mRNA, tRNA, rRNA).
- Translation of mRNA using tRNA to specify amino acid sequence and produce proteins according to the genetic code.
Naked DNA And DNA Vaccines A Retrospectiverwmalonemd
A retrospective review starting from the genesis of genetic vaccination and naked gene delivery through development of cationic lipid and electroporative delivery of DNA (skin, muscle, liver, lung)
1. Nucleic acids are biopolymers made from nucleotides that are essential to all known forms of life. There are two main types of nucleic acids: DNA and RNA.
2. DNA contains the genetic instructions used in the development and functioning of all living organisms. RNA plays key roles in coding, decoding, regulating, and expressing genes.
3. The key differences between DNA and RNA are that DNA contains the sugar deoxyribose and uses the base thymine, while RNA contains the sugar ribose and replaces thymine with uracil.
The document discusses the key differences between nucleic acids RNA and DNA. It notes that RNA and DNA are made up of nucleotides, which consist of a nitrogenous base, a pentose sugar, and a phosphate group. The main differences are that RNA contains the sugar ribose and the base uracil, while DNA contains the sugar deoxyribose and the base thymine. DNA forms a double helix structure.
The document discusses druggability considerations for G protein-coupled receptors (GPCRs) and ion channels. It outlines challenges in central nervous system (CNS) drug development and the potential of beta-secretase (BACE) inhibitors for treating Alzheimer's disease. It also discusses the properties of BACE inhibitors and challenges in developing them, including achieving inhibition in the CNS. Finally, it provides examples of early BACE inhibitors that incorporated hydroxyethylamine (HEA) motifs and emerging methods to truncate the HEA.
Biochem introduction to genetics(june.15.2010)MBBS IMS MSU
1. Genetics is the study of heredity and how genes are passed from parents to children, determining traits like height, hair color, and eye color.
2. A gene is a sequence of DNA that codes for a polypeptide or RNA. In 1953, Watson and Crick revealed that DNA has a double helix structure with nucleotides pairing in a specific way.
3. DNA is located in the cell nucleus of eukaryotes and bound to proteins to form chromatin. Less than 0.1% of DNA is in mitochondria.
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...Alexander Decker
This document describes the synthesis of novel quinazolinone derivatives. Specifically, it details:
1) The synthesis of compound 1 which serves as the starting material.
2) The reaction of compound 1 with various reagents to yield Schiff bases, cyclic, and acyclic derivatives. This includes reactions with aldehydes, ketones, chloroacetyl chloride, and various nucleophiles.
3) Characterization of the synthesized derivatives using techniques like IR, mass, 1H-NMR, and elemental analysis to confirm their structures.
The goal is to gain a better understanding of the reaction pathways and structure-property relationships of these quinazolinone derivatives which have potential biological activities
Biological molecules (chemical tests and nucleic acids) proteins and Lipids r...Jorge Pinto
The document discusses chemical tests for biological molecules like carbohydrates, proteins, lipids, and nucleic acids. It describes the basic structure of DNA as a double helix consisting of nucleotides with phosphate, sugar, and nitrogenous base components. DNA contains the genetic instructions for life and encodes hereditary information through its sequence of nucleotide base pairs between strands. RNA is similar to DNA but is usually single-stranded and found in the nucleus.
The document discusses the synthetic, analytical, and therapeutic aspects of the pyrazole heterocyclic nucleus. Pyrazole rings are found in many pharmaceutical drugs due to their ease of preparation and important biological activities. Some key points:
- Pyrazoles have anti-inflammatory, antipyretic, antimicrobial, anticancer, and other therapeutic properties.
- They contain an NH group that allows for hydrogen bonding and complex formation.
- Reduction or oxidation at nitrogen atoms in the ring can yield derivative structures.
- Many established drug molecules contain the pyrazole nucleus, including celecoxib, phenylbutazone, and apixaban.
Vibha Jagdevprasad Pandey submitted a thesis to the University of Mumbai in 2008 for a Doctor of Philosophy degree in Organic Chemistry. The thesis, supervised by Dr. Uday C. Mashelkar, studied oxazole, benzimidazole, oxadiazole, and related compounds. It synthesized novel coumarin and chromone derivatives containing imidazole, oxazole, oxadiazole substitutions and ligands based on these systems. Transition metal complexes of the ligands were also studied for applications in pharmacology, industry, and as metal ion sensors.
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfChart Kalyan
A Mix Chart displays historical data of numbers in a graphical or tabular form. The Kalyan Rajdhani Mix Chart specifically shows the results of a sequence of numbers over different periods.
Taking AI to the Next Level in Manufacturing.pdfssuserfac0301
Read Taking AI to the Next Level in Manufacturing to gain insights on AI adoption in the manufacturing industry, such as:
1. How quickly AI is being implemented in manufacturing.
2. Which barriers stand in the way of AI adoption.
3. How data quality and governance form the backbone of AI.
4. Organizational processes and structures that may inhibit effective AI adoption.
6. Ideas and approaches to help build your organization's AI strategy.
The document describes improvements made to the process for manufacturing the potential therapeutic compound ELN 296571. It summarizes the original multi-step synthesis route and key intermediate compound ELN 361973. The route was optimized to require fewer steps and produce ELN 361973 in higher yields and purity. Later, production of the important intermediate ELN 361973 was outsourced to improve the overall process.
This document discusses purine and pyrimidine metabolism. It covers the biosynthesis of purines through 11 steps, degradation of purines to uric acid, medical conditions related to purine metabolism like Lesch-Nyhan and ADA deficiency, the causes and treatment of gout, and drugs used to treat gout like colchicine, probenecid, and allopurinol.
Esta ha sido una de las conferencias que mas me ha gustado darla por lo moderno en el tratamiento de la DBM tipo 2 ,con el uso de la Linagliptina completamos el cuadro
The Mitsunobu reaction allows the conversion of alcohols to various functional groups using trialkyl/triaryl phosphine and dialkyl azodicarboxylate reagents. It proceeds via an oxidation-reduction mechanism. Common applications include esterification, etherification, and N-alkylation reactions. Recent advances have focused on replacing conventional reagents to improve selectivity and yields. The Mitsunobu reaction has been widely used in the synthesis of natural products and pharmaceuticals.
The document discusses factors that determine the biological activity of phosphodiesterase inhibitors. It finds that inhibitory activity mainly depends on bond stretch energy, geometric section, number of types of molecular associates, molecule surface area, sum of atomic volumes, and sum of free carbon atomic volumes and surfaces. Inhibitory activity is influenced by the molecule's geometry and ability to complementarily fit and strongly interact with the binding site. Virtual receptor modeling shows the most active structure occupying the receptor space most completely.
This document summarizes the optimization of an organocatalytic domino Michael-Aldol reaction to synthesize bispirooxindoles. Various cinchona alkaloid derivatives were evaluated as catalysts, with a trifunctional S-binaphthyl diamine catalyst (VIII) giving excellent diastereoselectivity and enantioselectivity. Reaction conditions such as temperature, solvent, and substrate scope were varied, demonstrating good yields and selectivity for a range of substrates. A different protecting group was also investigated, and bispirooxindoles were successfully deprotected to give the corresponding amines in high yields and selectivity.
The document lists 12 chemical reactions and asks the reader to identify missing dipoles, dipolarophiles, and cycloducts in each case. The reactions involve azide substitutions, halogenations, nitrene additions, and 1,3-dipolar cycloadditions to form five-membered heterocycles. Key intermediates and products include azides, nitriles, oxazoles, isoxazoles, and triazoles.
The big topic of the last few years, the use of small organic molecules to catalyse enantioselective transformations. This lecture will start with proline before moving on to some of MacMillan's contributions to this field and, finally, finish with hydrogen bond catalysts and Brønsted acids.
This chapter outline discusses DNA and RNA structure and function, including:
- The discovery that DNA is the genetic material through experiments with viruses.
- The double helix structure of DNA determined by Watson and Crick based on data from Franklin and others.
- DNA replication through semiconservative replication to produce identical copies.
- Transcription of DNA to mRNA and the three types of RNA (mRNA, tRNA, rRNA).
- Translation of mRNA using tRNA to specify amino acid sequence and produce proteins according to the genetic code.
Naked DNA And DNA Vaccines A Retrospectiverwmalonemd
A retrospective review starting from the genesis of genetic vaccination and naked gene delivery through development of cationic lipid and electroporative delivery of DNA (skin, muscle, liver, lung)
1. Nucleic acids are biopolymers made from nucleotides that are essential to all known forms of life. There are two main types of nucleic acids: DNA and RNA.
2. DNA contains the genetic instructions used in the development and functioning of all living organisms. RNA plays key roles in coding, decoding, regulating, and expressing genes.
3. The key differences between DNA and RNA are that DNA contains the sugar deoxyribose and uses the base thymine, while RNA contains the sugar ribose and replaces thymine with uracil.
The document discusses the key differences between nucleic acids RNA and DNA. It notes that RNA and DNA are made up of nucleotides, which consist of a nitrogenous base, a pentose sugar, and a phosphate group. The main differences are that RNA contains the sugar ribose and the base uracil, while DNA contains the sugar deoxyribose and the base thymine. DNA forms a double helix structure.
The document discusses druggability considerations for G protein-coupled receptors (GPCRs) and ion channels. It outlines challenges in central nervous system (CNS) drug development and the potential of beta-secretase (BACE) inhibitors for treating Alzheimer's disease. It also discusses the properties of BACE inhibitors and challenges in developing them, including achieving inhibition in the CNS. Finally, it provides examples of early BACE inhibitors that incorporated hydroxyethylamine (HEA) motifs and emerging methods to truncate the HEA.
Biochem introduction to genetics(june.15.2010)MBBS IMS MSU
1. Genetics is the study of heredity and how genes are passed from parents to children, determining traits like height, hair color, and eye color.
2. A gene is a sequence of DNA that codes for a polypeptide or RNA. In 1953, Watson and Crick revealed that DNA has a double helix structure with nucleotides pairing in a specific way.
3. DNA is located in the cell nucleus of eukaryotes and bound to proteins to form chromatin. Less than 0.1% of DNA is in mitochondria.
1.[1 9]use of 2-{[5-(2-amino-4-oxoquinazolin-3(4 h)-yl)-1,3,4-thiadiazol-2-yl...Alexander Decker
This document describes the synthesis of novel quinazolinone derivatives. Specifically, it details:
1) The synthesis of compound 1 which serves as the starting material.
2) The reaction of compound 1 with various reagents to yield Schiff bases, cyclic, and acyclic derivatives. This includes reactions with aldehydes, ketones, chloroacetyl chloride, and various nucleophiles.
3) Characterization of the synthesized derivatives using techniques like IR, mass, 1H-NMR, and elemental analysis to confirm their structures.
The goal is to gain a better understanding of the reaction pathways and structure-property relationships of these quinazolinone derivatives which have potential biological activities
Biological molecules (chemical tests and nucleic acids) proteins and Lipids r...Jorge Pinto
The document discusses chemical tests for biological molecules like carbohydrates, proteins, lipids, and nucleic acids. It describes the basic structure of DNA as a double helix consisting of nucleotides with phosphate, sugar, and nitrogenous base components. DNA contains the genetic instructions for life and encodes hereditary information through its sequence of nucleotide base pairs between strands. RNA is similar to DNA but is usually single-stranded and found in the nucleus.
The document discusses the synthetic, analytical, and therapeutic aspects of the pyrazole heterocyclic nucleus. Pyrazole rings are found in many pharmaceutical drugs due to their ease of preparation and important biological activities. Some key points:
- Pyrazoles have anti-inflammatory, antipyretic, antimicrobial, anticancer, and other therapeutic properties.
- They contain an NH group that allows for hydrogen bonding and complex formation.
- Reduction or oxidation at nitrogen atoms in the ring can yield derivative structures.
- Many established drug molecules contain the pyrazole nucleus, including celecoxib, phenylbutazone, and apixaban.
Vibha Jagdevprasad Pandey submitted a thesis to the University of Mumbai in 2008 for a Doctor of Philosophy degree in Organic Chemistry. The thesis, supervised by Dr. Uday C. Mashelkar, studied oxazole, benzimidazole, oxadiazole, and related compounds. It synthesized novel coumarin and chromone derivatives containing imidazole, oxazole, oxadiazole substitutions and ligands based on these systems. Transition metal complexes of the ligands were also studied for applications in pharmacology, industry, and as metal ion sensors.
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfChart Kalyan
A Mix Chart displays historical data of numbers in a graphical or tabular form. The Kalyan Rajdhani Mix Chart specifically shows the results of a sequence of numbers over different periods.
Taking AI to the Next Level in Manufacturing.pdfssuserfac0301
Read Taking AI to the Next Level in Manufacturing to gain insights on AI adoption in the manufacturing industry, such as:
1. How quickly AI is being implemented in manufacturing.
2. Which barriers stand in the way of AI adoption.
3. How data quality and governance form the backbone of AI.
4. Organizational processes and structures that may inhibit effective AI adoption.
6. Ideas and approaches to help build your organization's AI strategy.
Programming Foundation Models with DSPy - Meetup SlidesZilliz
Prompting language models is hard, while programming language models is easy. In this talk, I will discuss the state-of-the-art framework DSPy for programming foundation models with its powerful optimizers and runtime constraint system.
Your One-Stop Shop for Python Success: Top 10 US Python Development Providersakankshawande
Simplify your search for a reliable Python development partner! This list presents the top 10 trusted US providers offering comprehensive Python development services, ensuring your project's success from conception to completion.
HCL Notes and Domino License Cost Reduction in the World of DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
Dandelion Hashtable: beyond billion requests per second on a commodity serverAntonios Katsarakis
This slide deck presents DLHT, a concurrent in-memory hashtable. Despite efforts to optimize hashtables, that go as far as sacrificing core functionality, state-of-the-art designs still incur multiple memory accesses per request and block request processing in three cases. First, most hashtables block while waiting for data to be retrieved from memory. Second, open-addressing designs, which represent the current state-of-the-art, either cannot free index slots on deletes or must block all requests to do so. Third, index resizes block every request until all objects are copied to the new index. Defying folklore wisdom, DLHT forgoes open-addressing and adopts a fully-featured and memory-aware closed-addressing design based on bounded cache-line-chaining. This design offers lock-free index operations and deletes that free slots instantly, (2) completes most requests with a single memory access, (3) utilizes software prefetching to hide memory latencies, and (4) employs a novel non-blocking and parallel resizing. In a commodity server and a memory-resident workload, DLHT surpasses 1.6B requests per second and provides 3.5x (12x) the throughput of the state-of-the-art closed-addressing (open-addressing) resizable hashtable on Gets (Deletes).
Digital Banking in the Cloud: How Citizens Bank Unlocked Their MainframePrecisely
Inconsistent user experience and siloed data, high costs, and changing customer expectations – Citizens Bank was experiencing these challenges while it was attempting to deliver a superior digital banking experience for its clients. Its core banking applications run on the mainframe and Citizens was using legacy utilities to get the critical mainframe data to feed customer-facing channels, like call centers, web, and mobile. Ultimately, this led to higher operating costs (MIPS), delayed response times, and longer time to market.
Ever-changing customer expectations demand more modern digital experiences, and the bank needed to find a solution that could provide real-time data to its customer channels with low latency and operating costs. Join this session to learn how Citizens is leveraging Precisely to replicate mainframe data to its customer channels and deliver on their “modern digital bank” experiences.
FREE A4 Cyber Security Awareness Posters-Social Engineering part 3Data Hops
Free A4 downloadable and printable Cyber Security, Social Engineering Safety and security Training Posters . Promote security awareness in the home or workplace. Lock them Out From training providers datahops.com
Monitoring and Managing Anomaly Detection on OpenShift.pdfTosin Akinosho
Monitoring and Managing Anomaly Detection on OpenShift
Overview
Dive into the world of anomaly detection on edge devices with our comprehensive hands-on tutorial. This SlideShare presentation will guide you through the entire process, from data collection and model training to edge deployment and real-time monitoring. Perfect for those looking to implement robust anomaly detection systems on resource-constrained IoT/edge devices.
Key Topics Covered
1. Introduction to Anomaly Detection
- Understand the fundamentals of anomaly detection and its importance in identifying unusual behavior or failures in systems.
2. Understanding Edge (IoT)
- Learn about edge computing and IoT, and how they enable real-time data processing and decision-making at the source.
3. What is ArgoCD?
- Discover ArgoCD, a declarative, GitOps continuous delivery tool for Kubernetes, and its role in deploying applications on edge devices.
4. Deployment Using ArgoCD for Edge Devices
- Step-by-step guide on deploying anomaly detection models on edge devices using ArgoCD.
5. Introduction to Apache Kafka and S3
- Explore Apache Kafka for real-time data streaming and Amazon S3 for scalable storage solutions.
6. Viewing Kafka Messages in the Data Lake
- Learn how to view and analyze Kafka messages stored in a data lake for better insights.
7. What is Prometheus?
- Get to know Prometheus, an open-source monitoring and alerting toolkit, and its application in monitoring edge devices.
8. Monitoring Application Metrics with Prometheus
- Detailed instructions on setting up Prometheus to monitor the performance and health of your anomaly detection system.
9. What is Camel K?
- Introduction to Camel K, a lightweight integration framework built on Apache Camel, designed for Kubernetes.
10. Configuring Camel K Integrations for Data Pipelines
- Learn how to configure Camel K for seamless data pipeline integrations in your anomaly detection workflow.
11. What is a Jupyter Notebook?
- Overview of Jupyter Notebooks, an open-source web application for creating and sharing documents with live code, equations, visualizations, and narrative text.
12. Jupyter Notebooks with Code Examples
- Hands-on examples and code snippets in Jupyter Notebooks to help you implement and test anomaly detection models.
Generating privacy-protected synthetic data using Secludy and MilvusZilliz
During this demo, the founders of Secludy will demonstrate how their system utilizes Milvus to store and manipulate embeddings for generating privacy-protected synthetic data. Their approach not only maintains the confidentiality of the original data but also enhances the utility and scalability of LLMs under privacy constraints. Attendees, including machine learning engineers, data scientists, and data managers, will witness first-hand how Secludy's integration with Milvus empowers organizations to harness the power of LLMs securely and efficiently.
Introduction of Cybersecurity with OSS at Code Europe 2024Hiroshi SHIBATA
I develop the Ruby programming language, RubyGems, and Bundler, which are package managers for Ruby. Today, I will introduce how to enhance the security of your application using open-source software (OSS) examples from Ruby and RubyGems.
The first topic is CVE (Common Vulnerabilities and Exposures). I have published CVEs many times. But what exactly is a CVE? I'll provide a basic understanding of CVEs and explain how to detect and handle vulnerabilities in OSS.
Next, let's discuss package managers. Package managers play a critical role in the OSS ecosystem. I'll explain how to manage library dependencies in your application.
I'll share insights into how the Ruby and RubyGems core team works to keep our ecosystem safe. By the end of this talk, you'll have a better understanding of how to safeguard your code.
Building Production Ready Search Pipelines with Spark and MilvusZilliz
Spark is the widely used ETL tool for processing, indexing and ingesting data to serving stack for search. Milvus is the production-ready open-source vector database. In this talk we will show how to use Spark to process unstructured data to extract vector representations, and push the vectors to Milvus vector database for search serving.
Main news related to the CCS TSI 2023 (2023/1695)Jakub Marek
An English 🇬🇧 translation of a presentation to the speech I gave about the main changes brought by CCS TSI 2023 at the biggest Czech conference on Communications and signalling systems on Railways, which was held in Clarion Hotel Olomouc from 7th to 9th November 2023 (konferenceszt.cz). Attended by around 500 participants and 200 on-line followers.
The original Czech 🇨🇿 version of the presentation can be found here: https://www.slideshare.net/slideshow/hlavni-novinky-souvisejici-s-ccs-tsi-2023-2023-1695/269688092 .
The videorecording (in Czech) from the presentation is available here: https://youtu.be/WzjJWm4IyPk?si=SImb06tuXGb30BEH .
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-EfficiencyScyllaDB
Freshworks creates AI-boosted business software that helps employees work more efficiently and effectively. Managing data across multiple RDBMS and NoSQL databases was already a challenge at their current scale. To prepare for 10X growth, they knew it was time to rethink their database strategy. Learn how they architected a solution that would simplify scaling while keeping costs under control.
A Comprehensive Guide to DeFi Development Services in 2024Intelisync
DeFi represents a paradigm shift in the financial industry. Instead of relying on traditional, centralized institutions like banks, DeFi leverages blockchain technology to create a decentralized network of financial services. This means that financial transactions can occur directly between parties, without intermediaries, using smart contracts on platforms like Ethereum.
In 2024, we are witnessing an explosion of new DeFi projects and protocols, each pushing the boundaries of what’s possible in finance.
In summary, DeFi in 2024 is not just a trend; it’s a revolution that democratizes finance, enhances security and transparency, and fosters continuous innovation. As we proceed through this presentation, we'll explore the various components and services of DeFi in detail, shedding light on how they are transforming the financial landscape.
At Intelisync, we specialize in providing comprehensive DeFi development services tailored to meet the unique needs of our clients. From smart contract development to dApp creation and security audits, we ensure that your DeFi project is built with innovation, security, and scalability in mind. Trust Intelisync to guide you through the intricate landscape of decentralized finance and unlock the full potential of blockchain technology.
Ready to take your DeFi project to the next level? Partner with Intelisync for expert DeFi development services today!
A Comprehensive Guide to DeFi Development Services in 2024
Dna and rna
1. Biochemistry of Medicinals I – Nucleic
Acids
Instructor: Natalia Tretyakova, Ph.D.
760E CCRB (Cancer Center)
Tel. 6-3432
e-mail trety001@umn.edu
Lecture: MWF 2:30-3:20 7-135 WDH
Web page: see “Web enhanced courses”
2.
3. Chapter 1. DNA Structure.
Required reading: Stryer 5th Edition p. 117-125, 144-146, 152, 745-750,
754-762, 875-877)
(or Stryer’s Biochemistry 4th edition p. 75-77,80-88, 119-122, 126-128,
787-799, 975-980)
4. DNA Structure: Chapter outline
1. Biological roles of DNA. Flow of genetic
information.
3. Primary and secondary structure of DNA.
5. Types of DNA double helix. Sequence-
specific DNA recognition by proteins.
7. Biophysical properties of DNA.
9. DNA topology. Topoisomerases.
11.Restriction Endonucleases. Molecular Cloning
5. Nucleic Acids
DNA RNA
(deoxyribonucleic acids) (ribonucleic acids)
Central Dogma of Biology
DNA RNA Proteins Cellular Action
replication
transcription translation
DNA
6. Why ?
Questions?
•How is genetic information transmitted to progeny cells?
•How is DNA synthesis initiated?
•What causes DNA defects and what are their biological an
physiological consequences?
•What causes the differences between cells containing the same
genetic information?
Relevance:
•Cancer: ex. Xeroderma pigmentosum
•Genetic diseases: ex., cystic fibrosis, sickle cell anemia, inborn
errors of metabolism
•Genetic typing: ex., drug metabolism
•Rational drug design: ex., antitumor and antimicrobial drugs
•Biotechnology: ex., growth hormones
7. The Building Blocks of DNA
Nucleotide
Purine or
Pyrimidine
O Base
5'
-O P O
O
β-N-glycosidic bond
1'
O- H H
4'
H 3' 2' H
O H(OH)
Phosphate
Pentose sugar
Nucleoside
8. DNA and RNA
nucleobases
NH2 O
7 6
N 5 1 N N
N N NH
8
4 2 N N
9N N N H
N NH2
H H
3
Purine Adenine (A) Guanine (G)
NH2 O
O
4
3 H3C
5 N N NH
NH
6 2
N1 N O N O
H N O
H H H
Pyrimidine Cytosine (C) Thymine (T) Uracil (U)
(DNA only) (RNA only)
12. Structural differences between DNA and RNA
DNA RNA
O O
H3C
NH NH
N O N O
H H
Thymine (T) Uracil (U)
HO CH2 HO CH2
O Base O Base
H H H H
H H
H H
O H O OH
2'-deoxyribose ribose
13. Preferred conformations of nucleobases and sugars in
DNA and RNA
NH2 NH2
N N
HO N O O N
HO
O
O
OH
OH
Anti conformation Syn conformation
Sugar puckers:
5.9 A
HO HO HO
BASE 3' BASE
5' 2' 5'
O 1' O 1'
7.0 A 3' H (OH)
HO H (OH)
2' endo (B-DNA) 3' endo (RNA)
14. Nucleosides Must Be Converted to
5’-Triphosphates to be Part of DNA and
RNA
O
HO
HO P O Base
Base
O Kinase HO O
ATP
OH OH
Monophosphate
ATP Kinase
O O O O O
HO P O P O P O HO P O P O
Base Kinase Base
HO OH OH O HO OH O
ATP
OH OH
Triphosphate Diphosphate
15. Linking in DNA biopolymer: DNA primary structure
DNA is
Arranged
5’ to 3’
Connected by
Phosphates
16. DNA secondary structure – double
helix
James Watson and Francis Crick, 1953- proposed a model for DNA
structure
Francis Crick Jim Watson
•DNA is the molecule of heredity (O.Avery, 1944)
•X-ray diffraction (R.Franklin and M. Wilkins)
•E. Chargaff (1940s) G = C and A = T in DNA
17. Watson-Crick model of DNA was based on X-ray
diffraction picture of DNA fibres
(Rosalind Franklin and Maurice Wilkins)
Rosalind Franklin
18. Watson-Crick model of DNA was consistent with
Chargaff’s base composition rules
Erwin Chargaff (Columbia University)
G = C and A = T in DNA
19. DNA is Composed of
Complementary Strands
Anti-parallel Strands
DNA RNA of DNA
N
O
N
O 5' 3'
H 2N H 2N
N NH N NH
N N
N N N N A :: T
NH 2 O NH 2 O
G•C G•C
N N G :::C
NH 2 NH 2
N O O
N
N N
HN HN T :: A
N N
N N
O O
A•T A•U 3' 5'
22. Forces stabilizing DNA double
helix
1. Hydrogen bonding (2-3 kcal/mol per base pair)
3. Stacking (hydrophobic) interactions
(4-15 kcal/mol per base pair)
3. Electrostatic forces.
23. B-
DNA
23.7 A •Sugars are in the 2’ endo
right handed helix
conformation.
HO
• helical axis passes through 5' 2' BASE
base pairs O 1'
3' H (OH)
7.0 A
HO
• planes of bases are nearly
perpendicular to the helix axis.
•Bases are the anti conformation.
NH2
• 3.4 A rise between base pairs
N
Wide and deep HO N O
O
OH
•Bases have a helical twist of 36º
Narrow and deep (10.4 bases per helix turn)
• Helical pitch = 34 A
24. DNA can deviate from the ideal Watson-Crick structure
• Helical twist ranges from 28 to 42°
• Propeller twisting 10 to 20°
•Base pair roll
25. Major groove and Minor groove of DNA
Hypothetical situation: the two grooves would have similar size if dR residues
were attached at 180° to each other
To deoxyribose-C1’ Base Base C1’ -To deoxyribose
Major groove Major groove
N NH 2
O
N
H 2N O
N
N NH N
N HN
N C-1’ N
N N
C-1’ NH 2 O O
e C-1’ C-1’
os To
rib d eox
xy yri
deo bo
se Minor groove
To
Minor groove
26. Major and minor groove of the
double helix
Major groove
N O
H2N
N NH
N
N N
e C-1’ NH2 O
os C-1’T
y rib od
eox
ox yri
de bo
To Minor groove se
N NH 2
Wide and deep O
N
N
HN
C-1’ N
N
O
C-1’
Narrow and deep
27. B-type duplex is not possible for
RNA
HO CH2
O Base
H H
H
H
O OH
ribose
steric “clash”
28. A-form helix: dehydrated DNA; RNA-DNA hybrids
Right handed helix
•Sugars are in the 3’ endo
conformation.
• planes of bases are tilted
20 ° relative the helix axis.
•Bases are the anti conformation.
• 2.3 A rise between base pairs
25.5 A
•11 bases per helix turn
• Helical pitch = 25.3 A
Top View
29. The sugar puckering in A-DNA is 3’-endo
5.9 A
O
5' 2' BASE
O O
O 3' BASE
1' 5'
7.0 A 3' H (OH) 1'
O
O 2'
H (OH)
2' endo (3' exo) B-DNA 3' endo (A-DNA)
30. A-DNA has a shallow minor
groove and a deep major
groove
Major groove
N O H2N
Major groove
os
eN NH• N
N To d
Helix axis •
O H2N
ib N eo N
yr xy
e ox NH2 O rib
os
d e e N NH N
To Minor groove os N To d
ib N eo
yr xy
ox NH2 O rib
de os
e
To Minor groove
B-DNA A-DNA
31. Z-form double helix: polynucleotides of
alternating purines and pyrimidines (GCGCGCGC) at
high salt
Left handed helix
• Backbone zig-zags because sugar
puckers alternate between 2’ endo
pyrimidines and 3’ endo (purines)
• planes of the bases are
tilted 9° relative the helix
axis. • Bases alternate between anti
(pyrimidines) and syn conformation
(purines).
• 3.8 A rise between base pairs
•12 bases per helix turn
18.4 A • Helical pitch = 45.6 A
• Flat major groove
• Narrow and deep minor groove
32. Sugar and base conformations in Z-DNA
alternate:
5’-GCGCGCGCGCGCG
3’-CGCGCGCGCGCGC
C: sugar is 2’-endo, base is anti
G: sugar is 3’-endo, base is syn
NH2
O
N HN
H2N N
HO
N O
5' 2' N
HO HO
O 1' 3' N
5'
3' H
O 1'
HO
C G H
33.
34. Biological relevance of the minor types of DNA
secondary structure
•Although the majority of chromosomal DNA is in B-form,
some regions assume A- or Z-like structure
• Runs of multiple Gs are A-like
•The upstream sequences of some genes contain
5-methylcytosine = Z-like duplex NH 2
H3C
N
N O
H
5-methylcytosine (5-Me-C)
• Structural variations play a role in DNA-protein interactions
• RNA-DNA hybrids and ds RNA have an A-type structure
Editor's Notes
In addition to these common bases, unusual nucleosides exist. Involved in gene regulation, Can be modified – 6-methyladenine, 5-methylcytosine As we will discuss in biochem 2 nucleosides have many other physiological functions dTMP = TMP
Base composition of a given organism is independent of the cell type
Only two types of base pairs can be accommodated without altering the positions of the sugars.
Each base is rotated 36 relative to its neighbor base (like a spiral staircase), so that 10 base pairs correspond to 1 helix turn.
Cooperative forces: each contributes a little, but adds up because DNA chains can be millions od nculeotides long.